BeOne Medicines Ltd. (ONC)
319.04
-33.19
(-9.42%)
USD |
NASDAQ |
Feb 26, 13:47
BeOne Medicines Free Cash Flow : 525.67M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| EvoNext Holdings SA | -1.228M |
| Kuros Biosciences Ltd. | -0.9723M |
| Basilea Pharmaceutica AG | 74.06M |
| Santhera Pharmaceuticals Holding AG | -47.55M |
| AC Immune SA | -61.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 403.20M |
| Cash from Investing (Quarterly) | -49.28M |
| Cash from Financing (Quarterly) | 963.17M |
| Free Cash Flow Per Share (Quarterly) | 3.101 |
| Free Cash Flow to Equity (Quarterly) | -524.21M |
| Free Cash Flow to Firm (Quarterly) | 365.82M |
| Free Cash Flow Yield | 1.48% |